About OmniSeq
OmniSeq is a company based in Buffalo (United States) founded in 2015. OmniSeq has raised $8.89 million across 5 funding rounds from investors including LabCorp and Hitachi High-Tech Corporation. OmniSeq offers products and services including OmniSeq INSIGHT. OmniSeq operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Buffalo, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Omniseq, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.89 M (USD)
in 5 rounds
-
Latest Funding Round
$1.57 M (USD), Series B
Jun 20, 2019
-
Investors
LabCorp
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OmniSeq
OmniSeq offers a comprehensive portfolio of products and services, including OmniSeq INSIGHT.
Comprehensive profiling for solid tumors to guide precision oncology treatments.
People of OmniSeq
Unlock access to complete
Funding Insights of OmniSeq
OmniSeq has successfully raised a total of $8.89M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $1.57 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OmniSeq
OmniSeq has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include LabCorp and Hitachi High-Tech Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Operations are maintained across multiple industries by the diversified conglomerate.
|
Locked | Locked | Locked | |
|
Provider of laboratory tests for physicians
|
Locked | Locked | Locked |
Investor details for OmniSeq
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OmniSeq
Investment portfolio details for OmniSeq
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OmniSeq
Detailed financials for OmniSeq
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Omniseq Comparisons
Peer comparison for OmniSeq
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OmniSeq
OmniSeq operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| Locked | Locked | Locked |
Diagnostic services are provided through laboratories and radiology units.
|
Detailed competitors of OmniSeq
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Omniseq
Complete news archive for OmniSeq
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OmniSeq
OmniSeq was founded in 2015 and raised its 1st funding round 2 years after it was founded.
OmniSeq is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
OmniSeq is a funded company, having raised a total of $8.89M across 5 funding rounds to date.
OmniSeq offers a suite of precision medicine solutions to physicians that claims to combine genomic data with information technology. The companys OmniSeq Target for lung cancer offers genomic sequencing services that can be ordered online by the physician. Its OmniSeq Connect is a web-based testing order entry that can be integrated into EHR and offers payment verification, coordination of specimen collection, access to testing reports online, and mobile and email updates. The companys OmniSeq Genomic Network is a physician network that offers access to molecular testing for cancer, access to molecular clinical trials tool and genomic network database.
OmniSeq's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
OmniSeq offers OmniSeq INSIGHT.
OmniSeq has 2 investors. Key investors include LabCorp, and Hitachi High-Tech Corporation.